Literature DB >> 23652295

Reply Re: "Drug-induced Graves disease from CTLA-4 receptor suppression".

Gary E Borodic, David M Hinkle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23652295     DOI： 10.1097/IOP.0b013e31828957c3

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN： 0740-9303            Impact factor:   1.746


× No keyword cloud information.
  3 in total

Review 1.  Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.

Authors:  Shannon K Quirk; Anna K Shure; Devendra K Agrawal
Journal:  Transl Res       Date:  2015-06-11       Impact factor: 7.012

2.  Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.

Authors:  Pauline Campredon; Philippe Imbert; Céline Mouly; Solange Grunenwald; Julien Mazières; Philippe Caron
Journal:  Eur Thyroid J       Date:  2018-01-04

Review 3.  Ocular side effects of biological agents in oncology: what should the clinician be aware of?

Authors:  Tobias Hager; B Seitz
Journal:  Onco Targets Ther       Date:  2013-12-24       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.